If the BOD has agreed a process for renewal through an independent search for the new director, and this process is already underway, then why try and push a new director in through the 'back door'? Why not see the process through to its completion? They did all agree on the consultant search after all.
What agenda do those who want to push Mr Williams through the back door have?
To that end, if Mr Williams is so keen to join the BOD, then why not throw his hat in the ring via the agreed search process with external consultants? Doing this would allow the BOD to maintain transparency in the process rather than 'jobs for mates', and I would think that would be something an incoming member of the Board would applaud.
This is just another side show created by management to distract from their core responsibility of creating and increasing shareholder value. Increasing shareholder value should be the number one priority of the MD, all day, every day.
Imagine if this amount of funding and energy was spent trying to find a new deal, new projects or expand existing projects.
Enough is enough.
- Forums
- ASX - By Stock
- WGO
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-47
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online